Golgi protein-73 (GP73) is a transmembrane glycoprotein located in type II Golgi apparatus [55], its increase of concentration occurs in such liver diseases as cirrhosis due to chronic HBV infection [56], focal nodular hyperplasia (FNH) [57], and HCC, in which elevated GP73 levels have been correlated with a shortened survival time—along with progressing cancerogenesis there occurs an increase in GP73 serum concentration [58]. Here, GOLM1 is linked to hepatocellular carcinoma.